Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan.
<h4>Background</h4>Real-world clinical data on psoriasis patients receiving different biological agents is needed, especially in Asian populations.<h4>Objectives</h4>Our aim is to compare and analyze the efficacy and safety profile of four biological agents (etanercept, adali...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0244620 |